Related at vwbg.org
HOPE: New validation for the importance of tissue ACE inhibition
The results of the recently published HOPE (Heart Outcomes Prevention Evaluation) study provide powerful confirmation of the clinical benefits of tissue angiotensin-converting enzyme (ACE) inhibition, now strikingly demonstrated in patients at high risk for cardiovascular events.
Vascular Biology in Clinical Practice © Vol. 7, No. 1
ACE Inhibition in CAD Patients: Expanding the Reach of Cardioprotection
This monograph, ACE Inhibition in CAD Patients: Expanding the Reach of Cardioprotection , which is being offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.
Curriculum Update # 7
Managing renal disease for risk reduction: The expanding role of ACE inhibition
Chronic renal disease is a problem of increasing magnitude in the United States.